A Study to assess the Safety, Tolerability and effect of RO7673396 when used alone as well as with other cancer medications in participants with Advanced Solid Tumors

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519622-20-00

Acronym

YO45758

Enrollment

Registered

2025-09-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumors Harboring RAS Mutation(S)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Denmark, France, Germany, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026